Good Pharma Scorecard

We rank companies on ethics and social responsibility performance criteria, focusing on issues that are critical to patients and public health.

The Good Pharma Scorecard ranks companies on their bioethics and social responsibility performance and governance, taking into account ethics and legal standards. Measures evaluate the integrity of clinical trial designs, the accessibility of medicines, marketing practices, diversity and fair inclusion, among other ethics and human rights issues. Below is a sample of our company and product rankings.

What we measure

Transparency and data-sharing practices

Clinical trial design integrity

Diversity, equity and fair inclusion in research and the workplace

Accessibility of medicines, vaccines and devices

Fair benefit-sharing

Marketing practices

Drug
Sponsor/Co-Sponsor
Indication
Drug
Sponsor/
Co-Sponsor
Indication
Transparency
Score
# 1 Avelumab Merck Merkel Cell Carcinoma
Merck
Merkel Cell Carcinoma
# 1 Dinutuximab United Therapeutics Neuroblastoma
United Therapeutics
Neuroblastoma
# 1 Trabectedin Johnson & Johnson / Janssen Liposarcoma
Johnson & Johnson / Janssen
Liposarcoma
# 4 Ponatinib Takeda CML
Takeda
CML
# 5 Olaratumab Eli Lilly Soft Tissue Sarcoma
Eli Lilly
Soft Tissue Sarcoma
# 6 Axicabtagene Ciloleucel Gilead Non-Hodgkin Lymphoma
Gilead
Non-Hodgkin Lymphoma
# 7 Carfilzomib Amgen Multiple Myeloma
Amgen
Multiple Myeloma
# 7 Durvalumab AstraZeneca Urothelial Cancer
AstraZeneca
Urothelial Cancer
# 7 Pertuzumab Roche Breast Cancer
Roche
Breast Cancer
# 10 Brigatinib Takeda Lung Cancer
Takeda
Lung Cancer
# 10 Ceritinib Novartis Lung Cancer
Novartis
Lung Cancer
# 10 Enasidenib Bristol-Myers Squibb Leukemia
Bristol-Myers Squibb
Leukemia
# 10 Ramucirumab Eli Lilly Gastric cancer
Eli Lilly
Gastric cancer
# 14 Necitumumab Eli Lilly Lung Cancer
Eli Lilly
Lung Cancer
# 14 Pembrolizumab Merck Melanoma
Merck
Melanoma
# 16 Abemaciclib Eli Lilly Breast Cancer
Eli Lilly
Breast Cancer
# 17 Bosutinib Pfizer CML
Pfizer
CML
# 17 Ibrutinib AbbVie Mantle Cell Lymphoma
AbbVie
Mantle Cell Lymphoma
# 17 Idelalisib Gilead Non-Hodgkin Lymphoma
Gilead
Non-Hodgkin Lymphoma
# 17 Omacetaxine Mepesuccinate Teva CML
Teva
CML
# 21 Rucaparib Clovis Oncology Ovarian Cancer
Clovis Oncology
Ovarian Cancer
# 22 Cobmetinib Roche / Genentech Melanoma
Roche / Genentech
Melanoma
# 22 Enzalutamide Pfizer Prostate Cancer
Pfizer
Prostate Cancer
# 22 Niraparib GlaxoSmithKline Ovarian Cancer
GlaxoSmithKline
Ovarian Cancer
# 25 Ixazomib Takeda Multiple Myeloma
Takeda
Multiple Myeloma
# 25 Nivolumab Bristol-Myers Squibb Melanoma
Bristol-Myers Squibb
Melanoma
# 27 Elotuzumab Bristol-Myers Squibb Multiple Myeloma
Bristol-Myers Squibb
Multiple Myeloma
# 28 Midostaurin Novartis AML
Novartis
AML
# 29 Blintumomab Amgen B-cell ALL
Amgen
B-cell ALL
# 29 Radium-223 Dichloride Bayer Prostate Cancer
Bayer
Prostate Cancer
# 29 Trastuzumab Emtansine Roche Breast Cancer
Roche
Breast Cancer
73% Median Median score

Median: 73%

# 32 Neratinib Puma Breast Cancer
Puma
Breast Cancer
# 32 Ribociclib Novartis Breast Cancer
Novartis
Breast Cancer
# 32 Ziv-Aflibercept Sanofi Colorectal Cancer
Sanofi
Colorectal Cancer
# 35 Afatinib Boehringer Ingelheim Lung Cancer
Boehringer Ingelheim
Lung Cancer
# 36 Inotuzumab Pfizer Leukemia
Pfizer
Leukemia
# 36 Osimertinib AstraZeneca Lung Cancer
AstraZeneca
Lung Cancer
# 36 Regorafenib Bayer Colorectal cancer
Bayer
Colorectal cancer
# 39 Acalabrutinib AstraZeneca Non-Hodgkin Lymphoma
AstraZeneca
Non-Hodgkin Lymphoma
# 40 Olaparib AstraZeneca Ovarian Cancer
AstraZeneca
Ovarian Cancer
# 40 Palbociclib Pfizer Breast Cancer
Pfizer
Breast Cancer
# 40 Panobinostat Novartis Multiple Myeloma
Novartis
Multiple Myeloma
# 40 Tisagenlecleucel Novartis ALL
Novartis
ALL
# 40 Trifluridine and Tipiracil Otsuka Colorectal Cancer
Otsuka
Colorectal Cancer
# 45 Alectinib Roche Lung Cancer
Roche
Lung Cancer
# 46 Lenvatinib Eisai Thyroid Cancer
Eisai
Thyroid Cancer
# 47 Axitinib Pfizer Renal Cell Carcinoma
Pfizer
Renal Cell Carcinoma
# 48 Pomalidomide Bristol-Myers Squibb Multiple Myeloma
Bristol-Myers Squibb
Multiple Myeloma
# 49 Dabrafenib GlaxoSmithKline Metastatic Melanoma
GlaxoSmithKline
Metastatic Melanoma
# 49 Sonidegib Novartis Basal Cell Carcinoma
Novartis
Basal Cell Carcinoma
# 49 Trametinib GlaxoSmithKline Metastatic Melanoma
GlaxoSmithKline
Metastatic Melanoma
# 52 Atezolizumab Roche Urothelial Cancer
Roche
Urothelial Cancer
# 53 Daratumumab Johnson & Johnson Multiple Myeloma
Johnson & Johnson
Multiple Myeloma
# 54 Belinostat Spectrum T-cell Lymphoma
Spectrum
T-cell Lymphoma
# 54 Cabozantinib Exelixis Thyroid cancer
Exelixis
Thyroid cancer
# 54 Copanlisib Bayer Non-Hodgkin Lymphoma
Bayer
Non-Hodgkin Lymphoma
# 54 Obinutuzumab Roche CLL
Roche
CLL
# 54 Venetoclax Abbvie Chronic Lymphocytic Leukemia
Abbvie
Chronic Lymphocytic Leukemia
# 54 Vismodegib Roche Basal Cell Carcinoma
Roche
Basal Cell Carcinoma